Informa (LON:INF) was upgraded by stock analysts at Peel Hunt to an “add” rating in a research note issued on Friday, May 4th. The brokerage currently has a GBX 740 ($9.93) target price on the stock. Peel Hunt’s target price would indicate a potential downside of 4.27% from the company’s previous close.
Several other research firms have also recently issued reports on INF. Deutsche Bank restated a “buy” rating on shares of Informa in a research report on Wednesday, January 17th. Liberum Capital restated a “buy” rating and set a GBX 855 ($11.47) price objective on shares of Informa in a research report on Monday, January 15th. JPMorgan Chase raised their price objective on shares of Informa from GBX 790 ($10.60) to GBX 808 ($10.84) and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Goldman Sachs restated a “conviction-buy” rating on shares of Informa in a research report on Friday, April 6th. Finally, Morgan Stanley restated an “overweight” rating and set a GBX 770 ($10.33) price objective on shares of Informa in a research report on Wednesday, March 14th. Six analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Informa presently has an average rating of “Buy” and a consensus target price of GBX 806.71 ($10.82).
Informa traded down GBX 6.20 ($0.08), hitting GBX 773 ($10.37), during midday trading on Friday, MarketBeat reports. 1,569,504 shares of the stock were exchanged, compared to its average volume of 3,640,000. Informa has a fifty-two week low of GBX 624.50 ($8.38) and a fifty-two week high of GBX 773 ($10.37).
Informa plc engages in business intelligence, academic publishing, and knowledge and events businesses worldwide. The company operates through Academic Publishing, Business Intelligence, Global Exhibitions, and Knowledge & Networking segments. The Academic Publishing segment publishes academic books and journals in print and digital formats for university libraries and departments, specialist research institutions, and individuals in the areas of humanities and social sciences, science, technology, and medicine.
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.